Michael specialises in the most disruptive technologies and companies across the Reagents space, with a particular focus on the use of Antibodies for clinical and research purposes. Partnering with market leading, global corporations to innovative small start ups, Michael has an extensive network of senior profiles across North America & EMEA. He has conducted a multitude of searches for a wide array of clients with extensive experience in scaling commercial teams and facilitating significant revenue growth.